“Efficacy, Durability, And Retreatment Outcomes Of Risankizumab In Moderate To Severe Plaque Psoriasis: Results From The Phase 3 Immhance Trial”. Journal of Carcinogenesis 15, no. 1 (December 25, 2016). Accessed March 17, 2026. https://carcinogenesis.com/index.php/JOC/article/view/1825.